Oncology Nursing News®

Don't miss real-time top news, insights, and interviews with the experts direct from the conference floor in Chicago. Sign up now to be reminded to tune in to OncLive News Network: On Location in Chicago.

Blood Cancers

Oral Rivaroxaban Reduces VTE in Outpatient Treatment of Patients With Cancer

Oral Rivaroxaban Reduces VTE in Outpatient Treatment of Patients With Cancer

BY KRISTIE L. KAHL

Treating Bone Disease Improves Myeloma Outcomes

Treating Bone Disease Improves Myeloma Outcomes

BY G. DAVID ROODMAN, MD, PHD

FDA Grants Lenalidomide/Rituximab Priority Review for Non-Hogkin Lymphoma Subtype

FDA Grants Lenalidomide/Rituximab Priority Review for Non-Hogkin Lymphoma Subtype

BY JASON M. BRODERICK

CAR T-Cell Therapy: Great Results, Major Toxicities

CAR T-Cell Therapy: Great Results, Major Toxicities

BY FREDERICK LOCKE, MD

FDA Grants Priority Review to Polatuzumab Vedotin Combination for R/R DLBC

FDA Grants Priority Review to Polatuzumab Vedotin Combination for R/R DLBC

BY KRISTIE L. KAHL

Expert Discusses Recent CLL Approval

Expert Discusses Recent CLL Approval

BY SUMAN KAMBHAMPATI, MD

FDA Approves Split Daratumumab Dosing Regimen for Myeloma Treatment

FDA Approves Split Daratumumab Dosing Regimen for Myeloma Treatment

BY BRIELLE BENYON

The V Foundation Announces Partnership with SAGERSTRONG Foundation to Fund Cancer Research in Memory of Craig Sager

The V Foundation Announces Partnership with SAGERSTRONG Foundation to Fund Cancer Research in Memory of Craig Sager

BY V FOUNDATION

FDA Approves Ibrutinib Plus Obinutuzumab in Frontline CLL/SLL

FDA Approves Ibrutinib Plus Obinutuzumab in Frontline CLL/SLL

BY GINA COLUMBUS

FDA Grants Umbralisib Breakthrough Designation for Marginal Zone Lymphoma

FDA Grants Umbralisib Breakthrough Designation for Marginal Zone Lymphoma

BY GINA COLUMBUS

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.